https://www.idival.org/wp-content/uploads/2022/05/cab-presentacion.jpg

An international study shows that combining immunotherapy with chemotherapy improves survival in stomach cancer

15 de December de 2025

Oncologist Fernando Rivera participates in the research published in The New England Journal of Medicine An international study has shown that adding an immunotherapy treatment to standard chemotherapy improves survival in patients with stomach cancer and gastroesophageal junction cancer who are eligible for surgery. The study, entitled “Perioperative Durvalumab in Gastric and Gastroesophageal Junction Cancer,” […]

Read more →

Researchers from IDIVAL and the DG of Public Health present findings on smoking among primary care personnel at the European Health Congress in Finland

12 de December de 2025

The research team from the Valdecilla Research Institute (IDIVAL) and the Directorate-General of Public Health of the Health Department of the Government of Cantabria took part in the European Health Congress held in Finland as part of the JA Prevent NCD project, where they presented the abstract titled “Trends in Tobacco Use Among Primary Care […]

Read more →

IDIVAL strengthens its commitment to the HRS4R Strategy and announces an institutional session on December 18

11 de December de 2025

The Marqués de Valdecilla Health Research Institute (IDIVAL) continues to make progress in consolidating the European Human Resources Strategy for Researchers (HRS4R), incorporating key improvements into its Action Plan and reinforcing its alignment with the recommendations of the European evaluation team. Following the latest meeting of the HRS4R working group and the joint review of […]

Read more →

Researchers in Cantabria review the role of the FoxP2 gene in schizophrenia

10 de December de 2025

A new study resulting from the collaboration between the Valdecilla Research Institute (IDIVAL), the Marqués de Valdecilla University Hospital, and the University of Cantabria (UC) has recently been published in the Journal of Psychiatric Research. The study, titled “FoxP2 and Schizophrenia: a systematic review”, was coordinated by Dr. Rosa Ayesa-Arriola and originated from a project […]

Read more →

Awareness campaign for “World No Alcohol Day”

5 de December de 2025

To mark “World No Alcohol Day”, the team from the JA Prevent NCD project at the Valdecilla Health Research Institute (IDIVAL), together with the Directorate-General for Public Health, carried out an awareness campaign on alcohol consumption in the municipality of Camargo. During the activity, the AUDIT-C questionnaire was administered to identify potential risky drinking habits […]

Read more →

Valdecilla hosted the “Rheumatology Excellence Preceptorship,” a leading program in advanced rheumatology training

3 de December de 2025

The Marqués de Valdecilla University Hospital hosted the “Rheumatology Excellence Preceptorship,” a high-level educational initiative in advanced rheumatology that brought together national and international specialists to update clinical, therapeutic, and research knowledge in the field. Directed by Dr. Ricardo Blanco, Head of the Rheumatology Department, and carried out in collaboration with Adium’s Immunology Division, the […]

Read more →

The second edition of the JACARDI courses arrives to improve the health of the population of Cantabria

2 de December de 2025

The Marqués de Valdecilla Health Research Institute (IDIVAL), through its Nursing Research Group, is launching this Wednesday, December 3, the second edition of the free online courses of the European JACARDI project, an initiative aimed at improving cardiovascular health and diabetes among the population of Cantabria. The training, open to all citizens, will run for […]

Read more →

IDIVAL participates in the conclusion of the European Health4EUkids project in Helsinki

1 de December de 2025

The Valdecilla Health Research Institute (IDIVAL) took part in the final meeting of the Health4EUkids project, held on November 10 and 11 in Helsinki (Finland). This initiative, developed as a Joint Action under the EU4Health programme and supported by the European Commission, brought together representatives from a dozen European countries to share progress and consolidate […]

Read more →

“Pint of Europe” held in Santander: An event to bring european funding opportunities closer to the research community

28 de November de 2025

Santander hosted a new edition of “Pint of Europe”, an event organized by the European Projects area of the Valdecilla Health Research Institute (IDIVAL), with the support of the Directorate-General for European Funds of the Government of Cantabria. The aim was to bring European funding opportunities closer to the region’s research community. The event took […]

Read more →

Representatives from IDIVAL and Valdecilla participate in the annual EUnetCCC meeting

27 de November de 2025

The Medical Oncology team from the Valdecilla Health Research Institute (IDIVAL) and the Marqués de Valdecilla University Hospital (HUMV) attended in Paris the first meeting of the European network of cancer centers, EUnetCCC, advancing Cantabria’s participation in the pilot accreditation program for Comprehensive Cancer Centers. The event brought togethhttps://www.humv.es/er nearly 1,000 health professionals, researchers, cancer […]

Read more →